Influence of isoproterenol and phosphodiesterase inhibitors on platelet- activating factor biosynthesis in the human neutrophil

Medicine & Life Sciences

• Phosphodiesterase Inhibitors 100%
• Platelet Activating Factor 97%
• 1-methylxanthine 95%
• Isoproterenol 83%
• Neutrophils 64%
• Phospholipases A2 29%
• O-deacetyl platelet activating factor 26%
• Leukotrienes 19%
• Ionophores 19%
• Arachidonic Acid 16%
• 2-arachidonoylglycero-3-phosphocholine 16%
• platelet factor 1 14%
• Type 4 Cyclic Nucleotide Phosphodiesterase 11%
• Rolipram 11%
• Glycerophospholipids 11%
• 1-Methyl-3-isobutylxanthine 11%
• Adrenergic Agonists 10%
• Ionomycin 10%
• Eicosanoids 9%
• Fura-2 9%
• Calcimycin 9%
• Transferases 8%
• Acetates 8%
• Fluorescence 6%
• Calcium 5%
• Pharmaceutical Preparations 3%